Ticker: APLS

Company: Apellis Pharmaceuticals, Inc.

Person: Caroline Baumal, officer

Transaction date: Jan. 22, 2026

Reporting date: Jan. 23, 2026

Average share price: 21.7654

Sold 2797.0 shares for 60877.82